Extract notice to the Minister
Kevzara (polymyalgie rhumatismale)
Common name / Subject : sarilumab
Name of the manufacturer : SanofiAven
Form : Sol. Inj. S.C. (ser); Sol. Inj. S.C. (stylo)
Dosage : ser: 200 mg/1,14 ml ; stylo: 200 mg/1,14 ml, 150 mg/1,14 ml
Name of the manufacturer : SanofiAven
Form : Sol. Inj. S.C. (ser); Sol. Inj. S.C. (stylo)
Dosage : ser: 200 mg/1,14 ml ; stylo: 200 mg/1,14 ml, 150 mg/1,14 ml
Indication : Traitement de la polymyalgie rhumatismale
INESSS' Recommendation
Inscription – Sous conditions
Minister's decisions
À venir
Evaluation published on August 25, 2026
INESSSid: 28266
Recevable on November 10, 2025